National Health Investors (NHI) Receivables - Other (2013 - 2026)

National Health Investors has reported Receivables - Other for 14 years, with the latest figure at $6.2 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other changed 0.0% year-over-year to $6.2 million; the trailing twelve-month figure through Mar 2026 stood at $6.2 million (changed 0.0% YoY), and the FY2025 full-year result was $6.2 million, changed 0.0% from the prior year.
• Receivables - Other for Q1 2026 stood at $6.2 million, roughly flat from $6.2 million in the prior quarter.
• The five-year high for Receivables - Other was $6.2 million in Q4 2022, with the low at $2.4 million in Q2 2022.
• Historically, Receivables - Other has averaged $5.7 million across 5 years, with a median of $6.2 million in 2022.
• Annual changes were most pronounced in 2022 — Receivables - Other changed 0.0% — and 2023, when it surged 158.67%.
• National Health Investors' Receivables - Other stood at $6.2 million in 2022, then changed by 0.0% to $6.2 million in 2023, then changed by 0.0% to $6.2 million in 2024, then changed by 0.0% to $6.2 million in 2025, then changed by 0.0% to $6.2 million in 2026.
• The last three Receivables - Other figures came in at $6.2 million (Q1 2026), $6.2 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.